Administration officials discuss remdesivir distribution, reopening and testing at Senate HELP hearing

May 12, 2020 - 03:40 PM
COVID19 Web Sized

The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said today at a Senate Health, Education, Labor and Pensions Committee hearing. "This has to be an evidence-based approach — getting the medical therapeutics, vaccines, remdesivir, whichever it happens to be, to the people in need," Hahn said. 

The committee posed questions around reopening, testing and vaccines. Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, M.D., said that communities that disregard "the checkpoints that we put in our guidelines about when it is safe to proceed in pulling back on mitigation" may "trigger an outbreak that you may not be able to control." Nursing home and long-term care facility testing and data reporting also were discussed.

Related News Articles

Headline
CMS Administrator Oz and Deputy Administrator Brillman discuss agency’s focus on innovation, reducing waste
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
CDC releases report on flu, COVID-19 vaccination coverage for health care workers for 2024-25 respiratory season 
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
Study estimates more than 155,000 uncounted COVID-19 deaths occurred early during pandemic 
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
CDC report highlights low use of COVID-19 antivirals among people 65 and older 
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…